The NF-κB/miR-488/ERBB2 axis modulates pancreatic cancer cell malignancy and tumor growth through cell cycle signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The NF-κB/miR-488/ERBB2 axis modulates pancreatic cancer cell malignancy and tumor growth through cell cycle signaling

Published:2022-03-28 Issue:1 Volume:23 Page:294-309
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Han Duo¹,Zhu Shaihong²,Li Xia³,Li Zhiqiang¹,Huang Hui¹,Gao Wenzhe¹,Liu Yunfei¹,Zhu Hongwei¹,Yu Xiao¹

Affiliation:

1. Department of Hepatopancreatobiliary Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China

2. Department of Gastrointestinal Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China

3. Department of Endocrinology, The Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China

Funder

National Natural Science Foundation of China

Science and Technology Project of Changsha, Hunan, China

Natural Science Foundation of Hunan Province

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2022.2054257

Reference47 articles.

1. The Distributional Characteristic and Growing Trend of Pancreatic Cancer in China

2. A systematic assessment of statistics, risk factors, and underlying features involved in pancreatic cancer

3. New therapeutic directions for advanced pancreatic cancer: cell cycle inhibitors, stromal modifiers and conjugated therapies

4. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

5. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ginsenoside Rh2 suppresses ferroptosis in ulcerative colitis by targeting specific protein 1 by upregulating microRNA-125a-5p;European Journal of Medical Research;2024-09-02

2. MicroRNA-based interventions in aberrant cell cycle diseases: Therapeutic strategies for cancers, central nervous system disorders and comorbidities;Biomedicine & Pharmacotherapy;2024-08

3. The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy;Molecular Therapy: Oncology;2024-06

4. Unraveling Proto-Oncogene (ErbB2) Expression in Patients With Carcinoma Head of Pancreas and Chronic Pancreatitis Patients: A Case-Control Study;Cureus;2024-02-25

5. MicroRNA-488: A miRNA with diverse roles and clinical applications in cancer and other human diseases;Biomedicine & Pharmacotherapy;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3